The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
- PMID: 32395216
- PMCID: PMC7202348
- DOI: 10.4084/MJHID.2020.027
The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
Keywords: Children; Cutaneous Leishmaniasis; Iraq; Kurdistan; Pediatric; Two years.
Conflict of interest statement
Competing interests: The authors declare no conflict of Interest.
References
-
- Al-Bajalan MMM, Al-Jaf SMA, Niranji SS, Abdulkareem DR, Al-Kayali KK, Kato H. An outbreak of Leishmania major from an endemic to a non-endemic region posed a public health threat in Iraq from 2014–2017: Epidemiological, molecular and phylogenetic studies. PLOS Neglected Tropical Diseases. 2018;12(3):e0006255. doi: 10.1371/journal.pntd.0006255. - DOI - PMC - PubMed
-
- Heras-Mosteiro J, Monge-Maillo B, Pinart M, Lopez Pereira P, Reveiz L, Garcia-Carrasco E, Campuzano Cuadrado P, Royuela A, Mendez Roman I, López-Vélez R. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev. 2017;11(11):CD005067–CD005067. doi: 10.1002/14651858.CD005067.pub5. - DOI - PMC - PubMed